Yulia M. Parkhomenko

Yulia M. Parkhomenko

Auto-generated profile, based on publicly available information

Yulia M. Parkhomenko

National Academy of Sciences of Ukraine

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GMGarik Mkrtchyan
Garik Mkrtchyan
VAVasily A. Aleshin
Vasily A. Aleshin
YPYulia Parkhomenko
Yulia Parkhomenko
TKThilo Kaehne
Thilo Kaehne
MSMartino Luigi Di Salvo
Martino Luigi Di Salvo
Victoria BunikVictoria Bunik
Victoria Bunik
Thiamin (vitamin B1) is a pharmacological agent boosting central metabolism through the action of the coenzyme thiamin diphosphate (ThDP). However, positive effects, including improved cognition, of high thiamin doses in neurodegeneration may be observed without increased ThDP or ThDP-dependent enzymes in brain. Here, we determine protein partners and metabolic pathways where thiamin acts beyond its coenzyme role. Malate dehydrogenase, glutamate dehydrogenase and pyridoxal kinase were identified as abundant proteins binding to thiamin- or thiazolium-modified sorbents. Kinetic studies, supported by structural analysis, revealed allosteric regulation of these proteins by thiamin and/or its derivatives. Thiamin triphosphate and adenylated thiamin triphosphate activate glutamate dehydrogenase. Thiamin and ThDP regulate malate dehydrogenase isoforms and pyridoxal kinase. Thiamin regulation of enzymes related to malate-aspartate shuttle may impact on malate/citrate exchange, responsible for exporting acetyl residues from mitochondria. Indeed, bioinformatic analyses found an association between thiamin- and thiazolium-binding proteins and the term acetylation. Our interdisciplinary study shows that thiamin is not only a coenzyme for acetyl-CoA production, but also an allosteric regulator of acetyl-CoA metabolism including regulatory acetylation of proteins and acetylcholine biosynthesis. Moreover, thiamin action in neurodegeneration may also involve neurodegeneration-related 14-3-3, DJ-1 and β-amyloid precursor proteins identified among the thiamin- and/or thiazolium-binding proteins.

6 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSergiy Chornyy
Sergiy Chornyy
YPYulia Parkhomenko
Yulia Parkhomenko
NCNataliya Chorna
Nataliya Chorna
Accumulating evidences suggest that p53 is a key coordinator of cellular events triggered by oxidative stress often associated with the impairment in thiamine metabolism and its functions. However, there are limited data regarding the pursuant feedback between p53 transactivation and thiamine homeostasis. Impairment in thiamine metabolism can be induced experimentally via interference with the thiamine uptake and/or inhibition of the thiamin pyrophosphate–dependent enzymes using thiamine antagonists - amprolium (AM), oxythiamine (OT) or pyrithiamine (PT). We found that exposure of neuronally differentiated SH-SY5Y cells to AM, OT and PT triggered upregulation of p53 gene expression, post-translational modification of p53 via phosphorylation and activation of p53 DNA-binding activity. Phosphorylation of p53 at Ser20 was equally efficient in upregulation of thiamine transporter 1 (THTR1) by all antagonists. However, induction of the expressions of the pyruvate dehydrogenase E1 component subunit beta (PDHB) and oxoglutarate dehydrogenase (OGDH) required dual phosphorylation of p53 at Ser9 and Ser20, seen in cells treated with PT and OT. Moreover, pretreatment of the cells with a decoy oligonucleotide carrying wild-type p53-response element markedly attenuated OT-induced THTR1, PDHB and OGDH gene expression suggesting an important role of p53 in transactivation of these genes. Finally, analysis of gene and metabolic networks showed that OT triggers cell apoptosis through the p53-dependent intrinsic pathway.

1 November 2021 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
OPO. Pavlova
O. Pavlova
SSS. Stepanenko
S. Stepanenko
LCL. Chehivska
L. Chehivska
MSM. Sambon
M. Sambon
LBL. Bettendorff
L. Bettendorff
YPYu Parkhomenko
Yu Parkhomenko

19 May 2011 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
YPYulia M. Parkhomenko
Yulia M. Parkhomenko
PKPavel A. Kudryavtsev
Pavel A. Kudryavtsev
SPSvetlana Yu. Pylypchuk
Svetlana Yu. Pylypchuk
LCLilia I. Chekhivska
Lilia I. Chekhivska
SSSvetlana P. Stepanenko
Svetlana P. Stepanenko
Victoria BunikVictoria Bunik
Victoria Bunik

1 December 2016 in Neurophysiology
Verified
Journal Article
Closed access
PDF file
YPYu. M. Parkhomenko
Yu. M. Parkhomenko
APA. S. Pavlova
A. S. Pavlova
OMO. A. Mezhenskaya
O. A. Mezhenskaya

14 June 2024 in Neurochemistry International
Verified
Journal Article
Closed access
YPYu.M. Parkhomenko
Yu.M. Parkhomenko
AVA.I. Vovk
A.I. Vovk
ZPZ.S. Protasova
Z.S. Protasova
SPS. Yu Pylypchuk
S. Yu Pylypchuk
SCS.A. Chorny
S.A. Chorny
SSS.P. Stepanenko
S.P. Stepanenko